Autolysis of bovine enteropeptidase heavy chain: evidence of fragment 118–465 involvement in trypsinogen activation  by Mikhailova, Anna G & Rumsh, Lev D
Autolysis of bovine enteropeptidase heavy chain:
evidence of fragment 118^465 involvement in trypsinogen activation
Anna G. Mikhailova*, Lev D. Rumsh
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya st. 16/10,
117871 Moscow GSP-7, Russia
Received 5 October 1998; received in revised form 20 November 1998
Abstract Variations in bovine enteropeptidase (EP) activity
were shown to result from autolysis caused by the loss of calcium
ions; the cleavage sites were determined. The native enzyme
preferred its natural substrate, trypsinogen (KM = 2.4 WM), to
the peptide and fusion protein substrates (KM = 200 and 125 WM,
respectively). On the other hand, the truncated enzyme composed
of the C-terminal fragment 466^800 of EP heavy chain and
intact light chain did not distinguish these substrates. The results
suggest that the N-terminal fragment 118^465 of the entero-
peptidase heavy chain contains a secondary substrate-binding site
that interacts directly with trypsinogen.
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1. Introduction
Enteropeptidase (enterokinase; EC 3.4.21.9) is a highly spe-
ci¢c processing protease of the duodenal mucosa that initiates
a cascade of reactions activating digestion enzymes [1]. The
¢rst reaction of this cascade is the conversion of trypsinogen
into trypsin via EP-catalyzed cleavage after the (Asp)4Lys
sequence. In naturally occurring proteins, this sequence has
been found only in N-terminal activation peptides of various
trypsinogens [2]. The bovine EP molecule consists of disul¢de-
linked heavy (135^120 kDa) and light (47 kDa) chains; the
latter is a trypsin-like serine protease (Fig. 1). It was found
that ca. 40% of the apparent molecular mass of EP is pro-
vided by glycosylation [3^5]. The enzyme is synthesized as a
single-chain precursor of 1035 amino acid residues and then
cleaved after Arg800 to produce the disul¢de-linked hetero-
dimer [5]. Earlier, we developed a preparative method for
purifying EP [6] and its inhibitor (DI) from the duodenum
[7]. A highly puri¢ed form of the enzyme was found to be
stabilized by calcium ions and did not contain any other pro-
teolytic enzyme contaminations [6]. The activity of these prep-
arations was an order of magnitude higher than of those
obtained by the previously described method of Liepnieks
and Light [3]. N-terminal sequencing (15 amino acid residues)
of the enzyme heavy chain was performed for the ¢rst time;
Ser118 of the precursor was shown to be the N-terminal resi-
due in the heavy chain of the active bovine EP [8] (Fig. 1).
Removal of the 1^117 fragment from the proEP molecule
during processing was earlier found only for the porcine en-
zyme [9].
A variety of fusion proteins containing the (Asp)4Lys se-
quence were hydrolyzed by the obtained EP preparations
[8,10,11]. Kinetic data indicated that the peptide and arti¢cial
protein substrates bound through the linker (Asp)4Lys se-
quence to the light (catalytic) chain; a secondary binding
site may participate in a more e⁄cient hydrolysis of the phys-
iological substrate trypsinogen [8,10].
Here, we studied the properties of the truncated enzyme
(EP autolysis product), which allowed the suggestion that
the secondary binding site lies within the N-terminal fragment
118^465 of the EP heavy chain.
2. Materials and methods
2.1. Materials
All reagents used were purchased from Sigma (United States), Serva
(Germany), Bio-Rad (United States), and Merck (Germany), if not
stated otherwise, and were of analytical grade. Bovine trypsin was
from the Plant of Medical Preparations (St. Petersburg, Russia). Basic
bovine protease inhibitor (BPI) was kindly provided by Dr. N.I. Lar-
ionova (Moscow State University, Russia). Bovine EP was isolated
and puri¢ed as described by Mikhailova and Rumsh [6]; EP inhibitor
from the duodenum (DI) was isolated as described by Mikhailova et
al. [7].
2.2. Protein determination
Protein was determined by the Bradford method [12] with a Bio-
Rad Protein Assay Kit, Standard 1 (bovine IgG) or spectrophoto-
metrically by the A2353A280 di¡erence [13].
2.3. Activity assay
EP activity was determined from the activation of trypsinogen ac-
cording to Liepnieks and Light [3] with some modi¢cations. The
amount of EP that produced 1.0 nmol of trypsin from trypsinogen
in the activation mixture within 1 min was taken as one unit of
activity. The reaction mixture contained EP (6 0.03 units/ml), 0.1 M
sodium acetate (pH 5.0), 50 mM CaCl2 (bu¡er A) and 50 Wl of tryp-
sinogen solution (1.0 mg/ml in 1 mM HCl) in a total volume of 0.5 ml
and was incubated for 30 min at 37‡C. The reaction was terminated
with 50 Wl of 1 M HCl. The tryptic activity in 75-Wl aliquots was
measured spectrophotometrically at 405 nm at 25‡C with 0.5 mg/ml
BAPNA [14] in 0.1 M Tris-HCl (pH 8.0) containing 50 mM CaCl2
and 10% dimethyl sulfoxide in a total volume of 1.5 ml. Trypsinogen
autoactivation was taken into account in the calculations (the amount
of trypsin resulting from trypsinogen autoactivation did not exceed
5^10% of the amount of EP-derived trypsin). The calibration curve
was plotted using known trypsin concentrations. The trypsin molar
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concentration in solutions was estimated by active-site titration with
Gdn-Bz-ONp [15]. Trypsinogen preparations (Sigma) were shown to
contain 75% of potentially active proenzyme. Kinetic parameters for
trypsinogen activation were determined at pH 5.0 and 8.0 at 37‡C [8].
The concentrations of EP solutions were determined by active-site
titration with Gdn-Bz-OMum according to Liepnieks and Light [3]
using trypsin titrated with Gdn-Bz-ONp as a standard. The activity of
pure EP (100%) in experiments was 1840 units/mg.
2.4. Substrate hydrolysis
Kinetic parameters for the GD4K-NA cleavage were determined as
described previously for the human EP [16]. The release of L-naph-
thylamine was followed with a Hitachi MPF-4 spectro£uorimeter with
excitation at 330 nm and emission at 410 nm [10].
The expression and puri¢cation of the fusion protein PrA-P26 were
described by Kutusov et al. [17]. The kinetic parameters of the PrA-
P26 cleavage were determined as described previously [10]. The initial
rate of substrate hydrolysis was estimated as a decrease in the area of
the PrA-P26 peak in the course of its incubation with EP by SE-
HPLC on an Ultropac TSK G-2000 SW column (0.75 cmU60 cm;
LKB) at a £ow rate of 0.5 ml/min; 25 mM sodium phosphate (pH
6.6) containing 0.2 M NaCl (bu¡er B) was used as an eluent.
2.5. EP autolysis in the presence of EDTA
The e¡ects of EDTA on EP activity and structure were studied
using the enzyme preparations puri¢ed in the absence of CaCl2 or
with lyophilized EP (Boehringer Mannheim, Germany).
Method A: 5 Wl of the freshly dissolved Boehringer EP (0.3 mg/ml
in H2O) was incubated with 1 mM EDTA in the absence or presence
of inhibitors (2 WM BPI, 2 WM DI, 5 WM OVO, or 5 WM STI) in 100 Wl
of 0.1 M Tris-HCl (pH 8.0) at 20‡C. The resulting enzyme concen-
tration was 70 nM. The control samples were incubated without
EDTA either in the presence or absence of inhibitors. 2-Wl aliquots
were withdrawn at di¡erent time intervals, diluted 1:100 with bu¡er
A, and the EP activity toward trypsinogen was measured. The reac-
tion mixture samples (30^45 Wl) were simultaneously analyzed by SE-
HPLC on a Toyo Soda TSK G 4000 SW column (0.75 cmU60 cm) in
bu¡er B at a £ow rate of 0.5 ml/min.
Method B: EP solutions (30^60 Wg in 0.1^0.6 ml of 3^10 mM Tris-
HCl, pH 8.0) were incubated with 1^2 mM EDTA at 20^37‡C for 16^
24 h. The active enzyme concentration was 0.65^1.7 WM. 2-Wl aliquots
were withdrawn at di¡erent time intervals, diluted 1000^1500-fold
with bu¡er A, and the EP activity towards trypsinogen was measured.
Incubation was performed up to the complete loss of the enzyme
activity. The protein solution was concentrated (s 10-fold) on a
Speed-Vac, diluted with the sample loading bu¡er for SDS-PAGE
(3% SDS and 2% L-mercaptoethanol), and incubated for denaturation
at 55^60‡C for 5^6 h. SDS-PAGE was carried out in 7% gel according
to Laemmli [18]. The protein bands were transferred onto Immobilon
membrane (Millipore, USA) by electroblotting, N-terminal amino
acid sequencing of the autolysis products was performed by auto-
mated Edman’s degradation with an Applied Biosystem 470 A gas-
phase sequencer.
3. Results and discussion
The known procedures of EP puri¢cation, including the
method of Liepnieks and Light [3], did not involve Ca2.
We found that, when the enzyme preparations had been pu-
ri¢ed without CaCl2, their long-term storage (for several
months) or incubation with EDTA (for several hours) resulted
in the appearance of the second EP form, the retention time of
which in SE-HPLC was higher as compared to the native
enzyme (Fig. 2). The proteolytic activity of this modi¢ed EP
towards trypsinogen comprised only several percent of the
initial enzyme activity; however, this form completely retained
its activity towards fusion protein substrates and GD4K-NA
(Table 1). The number of active sites in the modi¢ed EP did
not change as determined by titration with Gdn-Bz-OMum.
The increase in the retention time upon SE-HPLC testi¢ed
that an apparent decrease (approx. 2-fold) in the molecular
mass accompanied enzyme modi¢cation. The acceleration of
the modi¢cation process in the presence of EDTA (but not
phenanthroline) suggested that the loss of calcium ions by the
protein was the reason for this phenomenon. This suggestion
was con¢rmed by isolation and puri¢cation of EP in the pres-
ence of CaCl2 from the very ¢rst step. In this case, only the
high-molecular-weight EP form was obtained that could not
be converted into the truncated enzyme even upon long-term
incubation with EDTA. In the presence of BPI or DI, the
enzyme activity towards trypsinogen was completely retained
upon addition of EDTA; no transition into the modi¢ed form
was observed (Fig. 2). In the presence of STI or OVO, this
transition became somewhat slower (Fig. 2; it should be noted
that STI and OVO are not EP inhibitors, but STI has been
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Fig. 1. Schematic structure of bovine enteropeptidase and its truncated form.
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shown to inhibit the isolated light chain [4]). Therefore, we
may conclude that the EP modi¢ed form is an enzyme autol-
ysis product. Apparently, the process was intramolecular: the
autolysis rate of EP was independent of the enzyme concen-
tration. As a rule, removal of calcium ions from Ca2-con-
taining proteins makes their structure more unfolded, de-
creases their stability in the presence of various denaturing
agents and promotes autolysis [19]. Trypsin, which binds
one Ca2 ion per molecule [20], is an example of such en-
zymes.
After SDS-PAGE under reducing conditions (Fig. 3) and
electroblotting of the heavy chain fragments on Immobilon,
N-terminal amino acid sequences of the autolysis products
were determined. The 70^80 kDa protein band was shown
to be composed of the heavy chain C-terminal fragment be-
ginning with Thr466 (TIFQ) and the heavy chain N-terminal
fragment beginning with Ser118 (SIIV), i.e. with the N-termi-
nal residue of the active EP heavy chain [8]. Hence, in the
presence of Ca2 the EP heavy chain undergoes autolysis at
the peptide bond formed by the Lys465 carboxyl group. Note
that in the proEP amino acid sequence [5] the residue at
position 464 is glutamic acid, and the heavy chain does not
contain the EP-speci¢c sequence (Asp)4Lys [5]. However, the
central fragment of the heavy chain (residues 359^465) con-
tains not only Lys465, but also Lys360, Arg384 and Arg422 pre-
ceded by Glu residues [5] (Fig. 1). Sequencing of the broad
protein band of 56^66 kDa (Fig. 3) showed that these autol-
ysis products began with Ser118, probably representing the N-
terminal fragments derived by the heavy chain cleavage by the
above-mentioned basic residues. Indeed, in some experiments
we found another C-terminal fragment with the N-terminal
sequence TQGS resulting from the heavy chain fragment au-
tolysis at Arg384. Heavy chain fragments beginning with
Val423 and Thr466 were previously found in EP commercial
preparations [21]. Their presence was ascribed to trypsin-like
contaminations [21], but we consider them to be EP autolysis
products. Fragment 466^800 of the EP heavy chain is obvi-
ously the terminal product of enzyme autolysis (Fig. 1). The
speci¢city of autolysis and the structural aspects will be dis-
cussed in our future publications. In the presence of various
di¡erent denaturing agents, EP may undergo autolysis in the
Ca2-independent manner. Thus, we ascribed the appearance
of the 115 kDa minor protein band (Fig. 3) to the extra
cleavage of the EP heavy chain at Lys234 under the SDS treat-
ment of the sample.
By using fusion proteins with the (Asp)4Lys linker se-
quence, we signi¢cantly increased the number of substrates
suitable for experimental studies of this highly speci¢c enzyme
and determined for the ¢rst time the catalytic parameters of
the fusion protein hydrolysis with EP [10]. To diminish the
probability of trypsinogen autoactivation at pH 8.0 the EP
activity is usually determined from the rate of trypsinogen
activation at pH 5.0^6.0 rather than at the pH optimum of
7.0^8.0 [3]. We estimated for the ¢rst time the kinetic param-
eters of trypsinogen activation not only at pH 5.0, but also at
the optimal pH for more correct comparison of hydrolysis
parameters of various substrates. In the case of EP puri¢ed
in the presence of Ca2 the kinetic parameters were deter-
mined at pH 8.0 for a series of substrates containing the
(Asp)4Lys sequence: the low-molecular substrate GD4K-NA
(KM = 200 WM, kcat = 1000 min31), fusion protein PrA-P26
(KM = 125 WM, kcat = 157 min31) and the natural substrate
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Fig. 2. Autolysis of the calcium-free EP preparation (0.1 WM) during incubation with 1 mM EDTA in the absence or presence of trypsin inhib-
itors in 0.1 M Tris-HCl (pH 8.0) at 20‡C: (a) EP and EDTA; (b) EP, EDTA, and STI or OVO (5 WM); (c) EP, EDTA, and BPI or DI
(2 WM); (d) control (EP). A: SE-HPLC on a Toyo Soda TSK G 4000 SW column after 120-min incubation. B: EP activity towards trypsino-
gen.
Table 1
Amounts of EP (standard EP units) required for hydrolysing the substrates tested at the initial rate of 1 nmol/min under standard conditions
for trypsinogen activation
Substrate Native enzyme (residues 118^1035) Truncated enzyme (residues 466^1035)
Trypsinogen, pH 5.0 1.0 100.0
Trypsinogen, pH 8.0 0.7 50.0
PrA-P26 73.6 73.6
GD4K-NA 18.3 18.3
The rates of trypsinogen activation by the native and truncated enzymes were determined experimentally as described in Section 2.3. Data for other
substrates were calculated with the determined KM and kcat values (see text).
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trypsinogen (KM = 2.4 and 1.8 WM, kcat = 700 and 435 min31
at pH 8.0 and 5.0, respectively) [8,10]. We believe that the
discrepancies between our and literature data on the KM
and kcat values for trypsinogen activation at acidic pH
(KM = 17 WM, kcat = 380 min31 [3]) are due to the admixture
of the truncated (low-active) EP form in the enzyme prepara-
tions obtained without Ca2. Recently, the kinetic constants
for GD4K-NA cleavage and trypsinogen activation were de-
termined for the native and recombinant bovine EP [22]. The
reported values agree well with our data. In the case of native
EP, the KM values for the fusion protein and the peptide
substrate were similar and appeared to be by two orders of
magnitude higher than those for trypsinogen. Moreover, the
KM values for the arti¢cial substrates were of the same order
of magnitude as the Ki values (100^140 WM) for the inhibition
of human and porcine EPs by the (Asp)4Lys peptide as de-
termined using trypsinogen and GD4K-NA as substrates
[23,24]. These results suggest that the peptide and fusion pro-
tein substrates bind to the enzyme through the linker sequence
(Asp)4Lys. More e⁄cient hydrolysis of trypsinogen, the nat-
ural substrate, provides evidence for a signi¢cant contribution
of other sites of the substrate and the enzyme to the produc-
tive binding [8,10]. The EP light chain is a trypsin-like serine
protease that contains the active site (Ser987, His841 and
Asp892) and the binding site (Lys886-Arg-Arg-Lys889) for the
(Asp)4 sequence of the substrate [5] (Fig. 1). The isolated light
(catalytic) chain was obtained by partial reduction and alky-
lation of the disul¢de bonds of bovine EP [4] ; cDNA encod-
ing this chain was expressed in various cell cultures [25^27].
The light chain was always less active towards trypsinogen as
compared to the native enzyme but retained its speci¢city and
e⁄ciency towards low-molecular substrates and fusion pro-
teins. Hence, we may conclude that the presence of the en-
zyme catalytic site and the binding site for the (Asp)4Lys
sequence is not enough for complete manifestation of the
natural features of EP; the presence of the heavy chain is
required for e⁄cient trypsinogen hydrolysis. The role of the
EP heavy chain has been discussed in the literature. The heavy
chain was proposed to serve only to anchor the catalytic chain
to the intestinal brush border and to orient it towards the
lumen [3,27]. However, its unusual mosaic structure (the pres-
ence of domains homologous to the segments of various re-
ceptors, complement components, metalloproteases [5]) indi-
cates its more important role. Comparison of the kinetic
parameters for a number of EP substrates [8,10], on the one
hand, and the data on the light chain structure and properties
[4,5], on the other hand, led us to the conclusion that binding
of the substrate (Asp)4Lys sequence occurs at the binding site
of the light chain, whereas physiological substrate trypsinogen
is additionally ¢xed at some secondary binding site located in
the heavy chain [8,10]. A series of experiments allowed Lu et
al. [22] to arrive at the same conclusion on the heavy chain
participation in the recognition of macromolecular substrates
and inhibitors. Two forms of recombinant EP were con-
structed: one containing the light chain and the main part
of the heavy chain (residues 198^800), the second consisting
of the light chain and the C-terminal fragment 784^800 of the
heavy chain [22]. The latter form di¡ered from the EP light
chain isolated earlier [4,25^27] by preserving the disul¢de
bond between the two EP chains. Kinetic parameters for tryp-
sinogen activation, GD4K-NA cleavage and inhibition by BPI
and STI were determined for these constructions and the nat-
ural bovine EP; these data indicate that the EP heavy chain
deletion had little e¡ect on the recognition of small substrates,
but strongly a¡ected macromolecular substrate recognition
and inhibitor speci¢city [22].
We believe that our present investigation may help in local-
izing the trypsinogen-binding site to the EP heavy chain. We
found the truncated form of EP which appeared to be the
product of enzyme autolysis resulting from the loss of calcium
ions by EP. This form contained the C-terminal fragment
(residues 466^800) of the heavy chain linked by the Cys788-
Cys912 disul¢de bond to the light chain (Fig. 1). The activity
of the truncated enzyme towards trypsinogen and low-molec-
ular substrates was similar to that of the isolated light chain.
The rate of trypsinogen activation by this modi¢ed enzyme
decreased by two orders of magnitude as compared to the
native enzyme and appeared to be similar to the hydrolysis
rates of peptides and fusion proteins with the EP-speci¢c se-
quence (Asp)4Lys (Table 1). These results may help in eluci-
dating the role in the EP heavy chain in trypsinogen recog-
nition: the secondary substrate-binding site that interacts
directly with trypsinogen [22] may be located in the N-termi-
nal fragment 118^465 (or, with respect to the data of Lu et al.
[22], fragment 198^465) of the heavy chain. The heavy chain
central fragment (residues 360^465) was shown to be the most
susceptible to Ca2-dependent autolysis. The EP heavy chain
has an unusual mosaic structure. It contains an assortment of
structural motifs found in other protein families ; the function
of these motifs in EP is unknown [5]. The fragment 358^520 is
homologous to the membrane-bound metalloprotease meprin
(the so-called MAM domain) [5]. Related domains in other
proteins bind ligands or mediate protein-protein interaction
[5]. In the EP heavy chain, the MAM domain along with
the sites of Ca2-dependent autolysis contains a substantial
amount of negatively charged amino acid residues, especially
between Lys360 and Arg385, providing the potential binding
site for calcium ions. Clari¢cation of the MAM domain role
in trypsinogen recognition and the features of its interaction
with EP active site in the presence and absence of Ca2 may
be of great importance for understanding the EP speci¢city.
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Fig. 3. SDS-PAGE of the autolysed sample (15 Wg) of Ca2-free EP
after incubation with EDTA; 7% gel, reducing conditions. Molecu-
lar mass markers (m) are indicated.
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